22 December 2008 (IRIN) - The world’s most clinically advanced malaria vaccine trials have given new hope in the fight against the disease, which in sub-Saharan Africa kills a child every 30 seconds. Malaria experts recently meeting in the Burkina Faso capital Ouagadougou say promising vaccine research aside, governments in West Africa must step up existing measures to prevent the spread of the disease. Results published on 11 December in the New England Journal of Medicine showed that the vaccine candidate RTS,S/AS (made by GlaxoSmithKline (GSK) Biologicals), provides both infants and young children with significant protection against malaria
Posted by TH. ROSENBERG MD.,PhD.